BetterLife Provides Important Update on its Australian Clinical Study Design
Go back to BetterLife Provides Important Update on its Australian Clinical Study Design| (NASDAQ: BETR) | Delayed: 27.30 +3.80 (16.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.50 | 52 Week High | $17.53 | |||
| Open | $23.62 | 52 Week Low | $9.15 | |||
| Day High | $27.45 | P/E | N/A | |||
| Day Low | $23.53 | EPS | $0.00 | |||
| Volume | 341,747 | |||||
| (AMEX: BETRF) | Delayed: 0.25 +0.04 (19.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.21 | 52 Week High | $ | |||
| Open | $0.21 | 52 Week Low | $ | |||
| Day High | $0.26 | P/E | N/A | |||
| Day Low | $0.21 | EPS | $ | |||
| Volume | 302,350 | |||||
